M.S. Fomin

M.S. Fomin

Auto-generated profile, based on publicly available information

M.S. Fomin

Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2025 in Russian Journal of Stomatology
Verified
Journal Article
Closed access
AGA.M. Gusarov
A.M. Gusarov
YSYu.A. Semenova
Yu.A. Semenova
MFM.S. Fomin
M.S. Fomin
MAM.S. Abin
M.S. Abin
BNB.N. Nassonov
B.N. Nassonov
ADA.V. Dudarov
A.V. Dudarov
Background. Digital technologies and artificial intelligence (AI) are increasingly being integrated into maxillofacial surgery, providing a higher level of precision, safety, and treatment personalization. Three-dimensional (3D) planning, CAD/CAM, and 3D printing contribute to improving the predictability of reconstructive procedures. Despite the growing body of evidence, there remains a need to systematize research results related to the implementation of AI and 3D technologies in this field. Objective. To summarize current evidence on the application of artificial intelligence and three-dimensional planning technologies in reconstructive and orthognathic maxillofacial surgery. Materials and methods. A systematic review was conducted in accordance with PRISMA guidelines. Publications from 2015 to 2025 were searched in the Cochrane Library, PubMed, Embase, and eLIBRARY.ru databases. Clinical trials, case reports, experimental study, a narrative reviews, systematic reviews, meta-analyses, and randomized controlled trials were included and assessed using AMSTAR 2 and ROB 2.0 tools. Results. Out of 514 identified publications, 43 studies met the inclusion criteria, 23 of which demonstrated high or moderate methodological quality. The use of CAD/CAM, virtual surgical planning, and machine learning algorithms was shown to improve the accuracy of bone segment positioning, reduce operative time and intraoperative errors, and enhance functional and aesthetic outcomes, as well as patients’ quality of life. Conclusion. The implementation of AI and 3D technologies in maxillofacial surgery significantly enhances the efficiency and predictability of reconstructive procedures. However, further clinical validation and the development of unified application standards are required.

30 December 2025 in Russian Journal of Stomatology
Verified
Journal Article
Closed access
TAT.SH. Andreasyan
T.SH. Andreasyan
KNK.G. Nalbandyan
K.G. Nalbandyan
EVE.L. Vinichenko
E.L. Vinichenko
YSYu.A. Semenova
Yu.A. Semenova
MFM.S. Fomin
M.S. Fomin
OLO.M. Lavrovskaya
O.M. Lavrovskaya
The article presents a review of clinical studies from the last 5 years on the effectiveness of various bone graft materials in sinus lifting. The analysis covers 8 studies with a sample of 448 patients. Autogenous, allogeneic, xenogeneic, and synthetic grafts are discussed, along with their impact on histological regeneration, clinical implant outcomes, and complications. Autogenous bone provides the highest proportion of new bone but is associated with high resorption and invasiveness. Allogeneic and xenogeneic materials yield lower but more stable results by maintaining volume due to slow resorption. Combinations of materials (e.g., autogenous + xenogeneic) and the addition of biological factors (platelets, bone marrow) showed comparable or better outcomes. The use of patient’s own tooth material and gene-activated matrices also demonstrated promise. Clinical outcomes remain high regardless of the material used. Complications (perforations, infections) are rare and not dependent on the type of material. The choice of approach should be individualized, considering anatomy and clinical situation, as no material showed absolute superiority.

12 May 2026 in Russian Journal of Stomatology
Verified
Journal Article
Closed access
MGM.ZH. Grigoryan
M.ZH. Grigoryan
MMM.K. Makeeva
M.K. Makeeva
KNK.G. Nalbandyan
K.G. Nalbandyan
DND.A. Nakonechny
D.A. Nakonechny
TAT.SH. Andreasyan
T.SH. Andreasyan
MKM.A. Kirushin
M.A. Kirushin
Inflammatory diseases of the oral mucosa (IDOM) represent a common group of pathologies, often becoming chronic and significantly reducing patients’ quality of life. Traditional therapeutic approaches, including antiseptics, corticosteroids, and analgesics, are frequently insufficient, as they do not address the underlying causes of inflammation and fail to prevent relapses. This highlights the need for new, more effective, and pathogenetically justified treatment strategies for IDOM. The aim of this study was to analyze modern therapeutic methods aimed at improving the clinical effectiveness of treating inflammatory diseases of the oral mucosa, with an assessment of their mechanisms of action. The main hypothesis was that low-level laser therapy (LLLT), probiotic therapy, and platelet-rich fibrin (PRF) could provide significant improvements in clinical outcomes and accelerate tissue healing. Materials and methods included an analysis of scientific publications in international and domestic databases (PubMed, Scopus, eLibrary) from 2015 to 2025. Clinical studies, literature reviews, and meta-analyses assessing the effectiveness of LLLT, probiotics, and PRF were included. Publications were selected based on methodological rigor, scientific validity, and availability of quantitative treatment outcome data. The results demonstrated high clinical efficacy of the investigated methods. LLLT provides rapid pain relief and accelerates tissue repair by activating cellular metabolism and improving microcirculation. Probiotics help normalize oral microbiota and reduce the risk of candidal complications. PRF accelerates wound healing through localized release of growth factors and stimulation of regenerative processes. The study concludes that these methods are advisable for inclusion in individualized, comprehensive therapy for IDOM, while standardization of treatment protocols and investigation of combined therapeutic schemes remain relevant.